Substantia Nigra
This graph shows the total number of publications written about "Substantia Nigra" by people in the URMC Research Network by year, and whether "Substantia Nigra" was a major or minor topic of these publication.
Below are the most recent publications written about "Substantia Nigra" by people in Profiles.
-
Nordeen EJ, Holtzman DA, Nordeen KW. Increased Fos expression among midbrain dopaminergic cell groups during birdsong tutoring. Eur J Neurosci. 2009 Aug; 30(4):662-70.
-
Cui M, Aras R, Christian WV, Rappold PM, Hatwar M, Panza J, Jackson-Lewis V, Javitch JA, Ballatori N, Przedborski S, Tieu K. The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A. 2009 May 12; 106(19):8043-8.
-
May PJ, McHaffie JG, Stanford TR, Jiang H, Costello MG, Coizet V, Hayes LM, Haber SN, Redgrave P. Tectonigral projections in the primate: a pathway for pre-attentive sensory input to midbrain dopaminergic neurons. Eur J Neurosci. 2009 Feb; 29(3):575-87.
-
Haber SN, Calzavara R. The cortico-basal ganglia integrative network: the role of the thalamus. Brain Res Bull. 2009 Feb 16; 78(2-3):69-74.
-
Chen X, Rzhetskaya M, Kareva T, Bland R, During MJ, Tank AW, Kholodilov N, Burke RE. Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo. J Neurosci. 2008 Jan 16; 28(3):672-80.
-
Miller RM, Kiser GL, Kaysser-Kranich T, Casaceli C, Colla E, Lee MK, Palaniappan C, Federoff HJ. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD. Exp Neurol. 2007 Mar; 204(1):421-32.
-
Luo Y, Henricksen LA, Giuliano RE, Prifti L, Callahan LM, Federoff HJ. VIP is a transcriptional target of Nurr1 in dopaminergic cells. Exp Neurol. 2007 Jan; 203(1):221-32.
-
Liang Q, Smith AD, Pan S, Tyurin VA, Kagan VE, Hastings TG, Schor NF. Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease. Biochem Pharmacol. 2005 Nov 1; 70(9):1371-81.
-
Miller RM, Kiser GL, Kaysser-Kranich TM, Lockner RJ, Palaniappan C, Federoff HJ. Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease. Neurobiol Dis. 2006 Feb; 21(2):305-13.
-
Cory-Slechta DA, Thiruchelvam M, Barlow BK, Richfield EK. Developmental pesticide models of the Parkinson disease phenotype. Environ Health Perspect. 2005 Sep; 113(9):1263-70.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
